Rankings
▼
Calendar
LNSR (LENSAR, Inc.) Stock Financials & Earnings | Market Cap Arena
LNSR
LENSAR, Inc.
Mkt Cap
$142M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$59M
Net Income (TTM)
-$52M
EPS (TTM)
-$4.39
Free Cash Flow (TTM)
-$12M
Gross Margin
45.8%
Op. Margin
-35.4%
Net Margin
-87.1%
FCF Margin
-20.1%
P/S Ratio (TTM)
2.4x
P/E Ratio (TTM)
—
YoY Rev Growth
+21.0%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 12
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$10M
$6M
-$3M
Q1 23
$8M
$4M
-$4M
Q2 23
$12M
$7M
-$3M
Q3 23
$10M
$5M
-$2M
Q4 23
$12M
$5M
-$3M
Q1 24
$11M
$5M
-$3M
Q2 24
$13M
$7M
-$2M
Q3 24
$14M
$6M
-$1M
Q4 24
$17M
$7M
-$1M
Q1 25
$14M
$7M
-$6M
Q2 25
$14M
$7M
-$6M
Q3 25
$14M
$6M
-$8M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
4.0x
—
Q1 23
4.1x
—
Q2 23
3.7x
—
Q3 23
3.5x
—
Q4 23
3.4x
—
Q1 24
3.2x
—
Q2 24
3.1x
—
Q3 24
2.9x
—
Q4 24
2.7x
—
Q1 25
2.5x
—
Q2 25
2.4x
—
Q3 25
2.4x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$5M
-$5M
Q1 23
-$7M
-$7M
Q2 23
-$2M
-$2M
Q3 23
-$339K
-$341K
Q4 23
-$480K
-$525K
Q1 24
-$5M
-$5M
Q2 24
-$4M
-$4M
Q3 24
$3M
$3M
Q4 24
$4M
$4M
Q1 25
-$7M
-$7M
Q2 25
-$5M
-$5M
Q3 25
-$4M
-$4M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$57K
Q1 23
$8K
Q2 23
$181K
Q3 23
$2K
Q4 23
$45K
Q1 24
$20K
Q2 24
$113K
Q3 24
$20K
Q4 24
$3K
Q1 25
$6K
Q2 25
$77K
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-8.8%
-15.1%
Q1 23
-11.6%
-21.3%
Q2 23
+49.4%
+0.3%
Q3 23
+26.4%
+0.0%
Q4 23
+18.3%
+17.3%
Q1 24
+28.3%
+6.5%
Q2 24
+5.2%
-4.7%
Q3 24
+38.2%
+23.0%
Q4 24
+38.2%
+19.6%
Q1 25
+33.7%
+48.5%
Q2 25
+10.3%
+42.6%
Q3 25
+5.7%
+50.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$2M
16.6%
Q1 23
$2M
20.9%
Q2 23
$2M
15.2%
Q3 23
$1M
12.0%
Q4 23
$816K
6.7%
Q1 24
$652K
6.2%
Q2 24
$683K
5.4%
Q3 24
$668K
4.9%
Q4 24
$662K
4.0%
Q1 25
$654K
4.6%
Q2 25
$766K
5.5%
Q3 25
$850K
5.9%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q4 22
$2M
$7M
Q1 23
$2M
$7M
Q2 23
$1M
$8M
Q3 23
$2M
$5M
Q4 23
$1M
$6M
Q1 24
$1M
$7M
Q2 24
$1M
$7M
Q3 24
$1M
$6M
Q4 24
$1M
$7M
Q1 25
$2M
$11M
Q2 25
$1M
$12M
Q3 25
$1M
$12M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$15M
$0
$15M
Q1 23
$8M
$0
$8M
Q2 23
$25M
$0
$25M
Q3 23
$25M
$0
$25M
Q4 23
$21M
$3M
$24M
Q1 24
$14M
$4M
$18M
Q2 24
$8M
$6M
$14M
Q3 24
$10M
$8M
$18M
Q4 24
$16M
$6M
$22M
Q1 25
$20M
$6M
$25M
Q2 25
$7M
$13M
$20M
Q3 25
$8M
$9M
$17M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
10M
+1.4%
Q1 23
11M
+3.4%
Q2 23
11M
+1.0%
Q3 23
12M
+10.5%
Q4 23
11M
-6.0%
Q1 24
11M
+1.3%
Q2 24
11M
+0.6%
Q3 24
12M
+1.3%
Q4 24
12M
+0.2%
Q1 25
12M
+1.3%
Q2 25
12M
+1.4%
Q3 25
12M
+0.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$264K
100
FY 21
$313K
110
FY 22
$321K
110
FY 23
$324K
130
FY 24
$382K
140
marketcaparena.com